Hojabr Kakavand
Ontario Institute for Cancer Research(CA)The University of Sydney(AU)German Cancer Research Center(DE)Heidelberg University(DE)Melanoma Institute Australia(AU)Keimyung University Dongsan Medical Center(KR)Keimyung University(KR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research
Most-Cited Works
- → Whole-genome landscapes of major melanoma subtypes(2017)1,452 cited
- → Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma(2012)799 cited
- → PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials(2014)388 cited
- → Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway(2015)282 cited
- → Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma(2017)244 cited
- → Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients(2017)217 cited